0.05Open0.17Pre Close2 Volume2.66K Open Interest83.00Strike Price10.00Turnover63.07%IV5.22%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0505Delta0.0434Gamma1578.60Leverage Ratio-0.1411Theta0.0001Rho79.71Eff Leverage0.0039Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet